Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

696
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
696
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

903
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
903
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

773
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
773
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

624
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
624
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

606
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
606

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracking outcome changes in benign prostatic hyperplasia trials: a version history review of ClinicalTrials.gov records.

Trials·2026
Same author

Explainable Machine Learning for Predicting Dengue Recovery Duration: Insights from Multi-Center Clinical Data.

Healthcare (Basel, Switzerland)·2026
Same author

Tranexamic acid in high-risk shoulder arthroplasty patients: safety across thromboembolic, cardiac, renal, and neurologic risk profiles.

Archives of orthopaedic and trauma surgery·2026
Same author

Triaging Factors of Caregiver Depression through Chi-Square Automatic Interaction Detection (CHAID) Analysis.

Journal of health care for the poor and underserved·2026
Same author

Underreporting of Adverse Events in Arrhythmia Therapy Trials.

Annals of emergency medicine·2026
Same author

Assessing the Diversity of Participants in US Colorectal Cancer Clinical Trials: A Comprehensive Review and Meta-Analysis.

JCO global oncology·2026

Related Experiment Video

Updated: Apr 23, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

777

Integrating Findings Into Practice: Assessing External Validity of Congestive Heart Failure Trials.

Lydia Hashemi1, Ryan Langerman1, Chance Bratten1

  • 1Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.

Cardiology Research
|April 22, 2026
PubMed
Summary

Randomized controlled trials (RCTs) for congestive heart failure (CHF) often lack external validity. Future CHF research should prioritize pragmatic principles and data transparency for improved clinical utility.

Keywords:
Congestive heart failureExternal validityPatient-centered outcomePragmatic clinical trialsRandomized controlled trialResearch transparency

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

949
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

2.2K

Related Experiment Videos

Last Updated: Apr 23, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

777
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

949
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

2.2K

Area of Science:

  • Cardiology
  • Clinical Trials
  • Health Services Research

Background:

  • Congestive heart failure (CHF) is a significant global health burden, leading to high hospitalization and mortality rates.
  • Randomized controlled trials (RCTs) are crucial for advancing CHF care, but their real-world applicability (external validity) is often questioned.
  • This study assesses the external validity of recent CHF RCTs using established criteria.

Purpose of the Study:

  • To evaluate the external validity of congestive heart failure randomized controlled trials published between 2014 and 2024.
  • To identify limitations in current RCTs regarding pragmatic principles, patient-centeredness, and data transparency.
  • To provide recommendations for enhancing the usefulness of future CHF clinical trials.

Main Methods:

  • A systematic literature search of MEDLINE and Embase was conducted up to April 1, 2025.
  • 44 full-text English-language human trials on CHF interventions were assessed using a 13-criterion guideline.
  • Data extraction and assessment were performed independently by two reviewers, with discrepancies resolved by consensus. Analysis included descriptive statistics and regression.

Main Results:

  • Only 15.9% of included CHF RCTs demonstrated significant information gain, and 4.5% adhered to pragmatic principles.
  • Patient-centeredness was fully addressed in 54.5% of trials, while feasibility was demonstrated in 38.6%.
  • Funding and conflict of interest disclosures were reported in 77.3% and 68.2% of studies, respectively. A positive trend in transparency and usefulness was observed over time.

Conclusions:

  • Many congestive heart failure RCTs require improvement in pragmatism, information value, statistical power, and data transparency.
  • Future CHF trials should emphasize pragmatic design, robust power calculations, economic analysis, and open data sharing.
  • Enhancing these aspects will improve the external validity and clinical impact of CHF research.